Vaccine News and Research

Latest Vaccine News and Research

Armed Forces members to support the Welsh Ambulance Service NHS Trust

An extra 184 Armed Forces members have been made available to support the Welsh Ambulance Service NHS Trust (WAST), to increase the resilience of emergency responders during the winter period.

23 Dec 2021

Over 4 million doses of University of Oxford-AstraZeneca vaccine donated by UK to Bangladesh

The UK donated over 4 million doses of the University of Oxford-AstraZeneca vaccine, made by Oxford Bio-medica in Oxford and packaged in Wrexham, North Wales, to Bangladesh through the COVAX vaccine sharing mechanism.

23 Dec 2021

Exploring immunity and severe disease caused by the SARS-CoV-2 Omicron variant

A new study describes the findings of a seroprevalence survey intended to establish the infection rates and the incidence of severe COVID-19 through December 15, 2021, in Gauteng, a crowded province that compresses a quarter of the country’s people into less than 2% of its area.

23 Dec 2021

Assessing the clinical severity of the SARS-CoV-2 Omicron variant

A recent preprint examines the proportion of Omicron infection and the risk of severe disease with this variant of SARS-CoV-2.

23 Dec 2021

Watch: One city’s effort to raise vaccination rates among Black residents

About 72% of Americans have received at least one dose of a covid-19 vaccine. During much of the vaccine rollout, Hispanic and Black Americans have been less likely than white Americans to get vaccinated.

23 Dec 2021

Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses

A new study shows that both antibody and cellular arms of the adaptive immune response against SARS-CoV-2 are displayed strong, sustained, and cross-reactive against other coronaviruses, in young children than the immune responses in adults.

23 Dec 2021

The transmission dynamics of SARS-CoV2 Omicron variant

In a recent study posted to the medRxiv* preprint server, researchers developed a coronavirus disease (COVID-19) model-inference system in South Africa to determine transmission dynamics and immune evasion associated with severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV-2) Omicron variant.

22 Dec 2021

New allocation model to optimize the distribution of COVID-19 vaccines, treatments

Lulu Kang, associate professor of applied mathematics at Illinois Institute of Technology and a team of researchers from the University of Illinois Chicago put a new twist on traditional resource allocation models to optimize the distribution of COVID-19 vaccines, treatments, testing supplies, and other related resources, publishing their findings, "Fair and Diverse Allocation of Scarce Resources," in Socio-Economic Planning Sciences.

22 Dec 2021

Decline in protection against SARS-CoV-2 Omicron in prior infected and fully vaccinated

In a recent study posted to the medRxiv* preprint server, researchers investigated the distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants among coronavirus disease 2019 (COVID-19) positive individuals who were either naive, fully vaccinated, or had a previous infection to further investigate possible escape from vaccine- or infection-induced immunity by Omicron compared to Delta.

22 Dec 2021

World leaders meet to discuss about COVID-19 vaccines, therapeutics and diagnostics

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization held high-level consultations with Gavi and UNICEF on 17 December, 2021 aimed at increasing the use of COVID-19 vaccines and other critical medical countermeasures in low-income (LIC) and lower middle-income (LMIC) countries and supporting countries to be better prepared, resourced, and ready to roll out vaccines.

22 Dec 2021

T-cell response to Omicron after an mRNA COVID vaccine booster

In a recent prospective observational study posted to the medRxiv* preprint server, researchers determined Omicron variant-associated T cell responses before and after a third dose of messenger ribonucleic acid (mRNA) vaccination against coronavirus disease (COVID-19) in anti-CD20-treated multiple sclerosis (MS) patients.

22 Dec 2021

All carers are encouraged to 'Get Boosted Now'

A new study, published today by the University of Birmingham and UCL, adds further evidence to the importance of a booster vaccine for both carers and care home residents as they are encouraged to Get Boosted Now.

22 Dec 2021

More breakthrough infections but less severe COVID-19 with Omicron

In a recent study posted to the bioRxiv* pre-print server, an international team of researchers reported the occurrence of coronavirus disease 2019 (COVID-19) breakthrough infections (BTIs) among health care workers (HCWs) participating in a phase III vaccine trial in Sisonke, South Africa.

22 Dec 2021

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

A recent review article discusses recent advances in protein-based nanoparticle vaccines against SARS-CoV-2.

22 Dec 2021

UK reaches milestone of 30 million boosters as the drive continues to Get Boosted Now

More than 30 million people, over 56% of adults in the UK, have now had their COVID-19 booster during a record-breaking week for top-up jabs.

22 Dec 2021

How COVID vaccines protected Americans against the Delta variant

A new study analyzed the COVID-19 breakthrough case and death rates among fully vaccinated individuals who were 12 years of age or above.

22 Dec 2021

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

Researchers developed four distinct recombinant vesicular stomatitis virus (rVSV)-based bivalent vaccines against SARS-CoV-2 and influenza virus.

22 Dec 2021

Importance of booster vaccine doses for maintaining protection against the SARS-CoV-2 Omicron variant

A new study shows that although the Omicron variant exhibits significant immune escape compared to other SARS-CoV-2 variants, antibody neutralization can be largely restored with booster doses of mRNA vaccines.

22 Dec 2021

MHRA approves new formulation of Pfizer BioNTech COVID-19 vaccine for 5-11 year olds

A new age-appropriate formulation of the Pfizer BioNTech COVID-19 vaccine (Comirnaty) for use in children aged 5 to 11 years old has been approved today by the Medicines and Healthcare products Regulatory Agency (MHRA) after finding that it is safe and effective.

22 Dec 2021

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

A new study proposes a multi-boost vaccine strategy with a longer duration between the second and third dose, as that would be beneficial in acquiring immunity against severely mutated SARS-CoV-2 variants.

22 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

Armed Forces members to support the Welsh Ambulance Service NHS Trust

Over 4 million doses of University of Oxford-AstraZeneca vaccine donated by UK to Bangladesh

Exploring immunity and severe disease caused by the SARS-CoV-2 Omicron variant

Assessing the clinical severity of the SARS-CoV-2 Omicron variant

Watch: One city’s effort to raise vaccination rates among Black residents

Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses

The transmission dynamics of SARS-CoV2 Omicron variant

New allocation model to optimize the distribution of COVID-19 vaccines, treatments

Decline in protection against SARS-CoV-2 Omicron in prior infected and fully vaccinated

World leaders meet to discuss about COVID-19 vaccines, therapeutics and diagnostics

T-cell response to Omicron after an mRNA COVID vaccine booster

All carers are encouraged to 'Get Boosted Now'

More breakthrough infections but less severe COVID-19 with Omicron

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

UK reaches milestone of 30 million boosters as the drive continues to Get Boosted Now

How COVID vaccines protected Americans against the Delta variant

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

Importance of booster vaccine doses for maintaining protection against the SARS-CoV-2 Omicron variant

MHRA approves new formulation of Pfizer BioNTech COVID-19 vaccine for 5-11 year olds

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in